Vivint Pharma
Hyderabad, India· Est.
Affordable critical‑care medicines from India for worldwide access.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Affordable critical‑care medicines from India for worldwide access.
Critical CareGeneral Medicine
Technology Platform
In‑house pharmaceutical chemistry and formulation science that combine process chemistry, biotech, and regulatory expertise to produce affordable, high‑quality critical‑care dosage forms.
Opportunities
Expanding demand for low‑cost critical‑care medicines in emerging markets and potential partnerships for contract manufacturing of injectables.
Risk Factors
Intense price competition, stringent regulatory requirements across multiple regions, and limited visibility into product pipeline and financial performance.
Competitive Landscape
Competes with large Indian generic manufacturers and global contract development organizations; differentiation hinges on cost‑efficiency, quality compliance, and a focused critical‑care portfolio.